Shares of Aurobindo Pharma Ltd were trading in the red and 1.5% lower on 8 April after the company announced receiving three observations from USFDA....
Shares of Aurobindo Pharma were trading in the green and 2% higher on 1 April after the company announced that, through its wholly-owned subsidiaries, it...
Aurobindo Pharma Limited shares were 2% lower after the company informed over its regulatory filing that its subsidiary APL Healthcare Limited got the World Health...
Pharmaceutical major Aurobindo Pharma Limited, on 12 February, announced that they have received approval from the USFDA (United States Food and Drug Administration) for Deflazacort...
Shares of pharma major Aurobindo Pharma gained 3% on 12 February after the company posted strong quarterly growth for October-December. The pharma company reported a...
Shares of Aurobindo Pharma plummeted 5% on 5 February after the pharma major halted production at one unit after USFDA issued 9 observations for its...
Aurobindo Pharma Ltd, on 27 December, announced that its wholly-owned arm Eugia Pharma Specialities Ltd had received final approval from the USFDA (US Food and...
Aurobindo Pharma shares hit a 52-week high of Rs 1,081.95 on 20 December after the company informed that its wholly owned subsidiary, APL Healthcare Limited,...